Nutrition
Volume 22, Issue 1 , Pages 36-46, January 2006

Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study

  • John D. Lloyd-Still, M.D.

      Affiliations

    • Rush University Medical Center, Chicago, Illinois, USA
    • Corresponding Author InformationCorresponding author. Tel.: +312-563-2132; fax: +312-563-2131
    • ,
  • Catherine A. Powers, R.D.

      Affiliations

    • Rush University Medical Center, Chicago, Illinois, USA
    • ,
  • Dennis R. Hoffman, Ph.D.

      Affiliations

    • Retina Foundation of the Southwest, Dallas, Texas, USA
    • ,
  • Katherine Boyd-Trull, B.S.

      Affiliations

    • Retina Foundation of the Southwest, Dallas, Texas, USA
    • ,
  • Lucille A. Lester, M.D.

      Affiliations

    • Rush University Medical Center, Chicago, Illinois, USA
    • ,
  • Diane C. Benisek, R.D.

      Affiliations

    • Martek Biosciences Corp., Columbia, Maryland, USA
    • ,
  • Linda M. Arterburn, Ph.D.

      Affiliations

    • Martek Biosciences Corp., Columbia, Maryland, USA

Received 20 November 2004; accepted 23 May 2005. published online 13 October 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was funded by Martek Biosciences Corporation, Columbia, Maryland, USA.

PII: S0899-9007(05)00231-5

doi:10.1016/j.nut.2005.05.006

Nutrition
Volume 22, Issue 1 , Pages 36-46, January 2006

Article Tools